BSX Stock May Gain From Newly Inked Deal to Buy Valencia TechnologiesZacks Investment Research • 01/15/26
Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing' vascular segmentsMarket Watch • 01/15/26
Boston Scientific Corporation (BSX) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26
Boston Scientific Announces Agreement to Acquire Valencia Technologies CorporationPRNewsWire • 01/12/26
Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?Zacks Investment Research • 01/08/26
Boston Scientific (BSX) Beats Stock Market Upswing: What Investors Need to KnowZacks Investment Research • 01/07/26
Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 resultsPRNewsWire • 01/02/26
How Is Boston Scientific's Cardiovascular Growth Path Shaping Up?Zacks Investment Research • 12/31/25
BSX vs. RMD: Which Medical Device Stock Is the Stronger Play Now?Zacks Investment Research • 12/30/25
Boston Scientific: Premium MedTech Growth Story With Attractive Valuation UpsideSeeking Alpha • 12/28/25
How Well Is Boston Scientific Placed for Long-Term Endoscopy Growth?Zacks Investment Research • 12/24/25
Boston Scientific (BSX) Stock Falls Amid Market Uptick: What Investors Need to KnowZacks Investment Research • 12/12/25